Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


MSCV-human Erbb2-IRES-GFP Citations (2)

Originally described in: Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.
Vo BT, Li C, Morgan MA, Theurillat I, Finkelstein D, Wright S, Hyle J, Smith SM, Fan Y, Wang YD, Wu G, Orr BA, Northcott PA, Shilatifard A, Sherr CJ, Roussel MF Cell Rep. 2017 Mar 21;18(12):2907-2917. doi: 10.1016/j.celrep.2017.02.073.
PubMed Journal

Articles Citing MSCV-human Erbb2-IRES-GFP

Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder Cancer. Erlangga Z, Wolff K, Poth T, Peltzer A, Nahnsen S, Spielberg S, Timrott K, Woller N, Kuhnel F, Manns MP, Saborowski A, Vogel A, Saborowski M. Cancers (Basel). 2019 Nov 29;11(12). pii: cancers11121904. doi: 10.3390/cancers11121904. PubMed
Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families. Van Marcke C, Helaers R, De Leener A, Merhi A, Schoonjans CA, Ambroise J, Galant C, Delree P, Rothe F, Bar I, Khoury E, Brouillard P, Canon JL, Vuylsteke P, Machiels JP, Berliere M, Limaye N, Vikkula M, Duhoux FP. Breast Cancer Res. 2020 Apr 15;22(1):36. doi: 10.1186/s13058-020-01273-y. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.